Resmed (RSMDF) Shares Outstanding (2009 - 2026)

Resmed (RSMDF) has reported Shares Outstanding (Entity) for 18 consecutive years, with $144.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) fell 1.47% year-over-year to $144.2 million; the trailing twelve-month figure through Jun 2026 stood at $144.2 million (down 1.47% YoY), and the FY2026 full-year result was $144.2 million, down 1.47% from the prior year.
• Shares Outstanding (Entity) retreated to $144.2 million in Q2 2026 per RSMDF's latest filing, from $145.0 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $147.1 million in Q4 2023 and bottomed at $144.2 million in Q2 2026.
• Historically, Shares Outstanding (Entity) has averaged $146.4 million across 5 years, with a median of $146.7 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Entity) gained 0.52% in 2022, then decreased 1.47% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $146.9 million in 2022, then gained by 0.13% to $147.1 million in 2023, then slipped by 0.16% to $146.9 million in 2024, then decreased by 0.81% to $145.7 million in 2025, then dropped by 0.98% to $144.2 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $144.2 million, $145.0 million, and $145.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.